Japan Platelet Rich Plasma (Prp) Market Size & Outlook
- Pharmaceuticals
- Blood Disorders Treatment
- Platelet Rich Plasma (PRP) Market Outlook
- Blood Disorders Treatment
Global Report
Related Markets
Ask a question about the platelet rich plasma (prp) market
Japan platelet rich plasma (prp) market highlights
- The Japan platelet rich plasma (prp) market generated a revenue of USD 30.1 million in 2025 and is expected to reach USD 97.6 million by 2033.
- The Japan market is expected to grow at a CAGR of 15.9% from 2026 to 2033.
- In terms of segment, pure prp was the largest revenue generating type in 2025.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2025 | USD 30.1 million |
| Market revenue in 2033 | USD 97.6 million |
| Growth rate | 15.9% (CAGR from 2026 to 2033) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP, Others Type |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Japan accounted for 4.6% of the platelet rich plasma (prp) market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, India platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2033.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 97.6 million by 2033.
In 2014, the "Act on the Safety of Platelet-rich Plasma (PRP)" and the "Pharmaceuticals, Medical Devices, and Other Therapeutic Products Act” were established by Japan for the regulation of platelet concentration therapies owing to their increasing popularity. Stringent regulations have been imposed for the correct use of PRP in terms of efficacy & specificity toward certain applications and dosage.
Furthermore, Japanese researchers have proposed point-of-care testing of PRP quality in research published in April 2019. In this study, researchers have emphasized the need for point-of-care quality testing to obtain supportive evidence for platelet-rich plasma therapy.
The point-of-care testing of platelet-rich plasma is an inexpensive and useful method for determining platelet count. This method can determine platelet count in PRP preparations, further supporting the therapy. Such recommendations are expected to positively impact the adoption of PRP therapies in the country, leading to significant market growth.
No credit card required*
Publish Date: Feb 11, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Stryker Corp | View profile | 52,000 | 1941 Stryker Way, Portage, MI, United States, 49002 | www.stryker.com |
| Zimmer Biomet Holdings Inc | View profile | 18,000 | 345 East Main Street, Warsaw, IN, United States, 46580 | www.zimmerbiomet.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | www.arthrex.com/ |
| EmCyte Corporation | View profile | 11-50 | Fort Myers, Florida, United States, North America | emcyte.com/ |
| Dr. PRP USA | View profile | 11-50 | Stafford, Texas, United States, North America | www.drprpusa.com |
| Juventix Regenerative Medical | View profile | 11-50 | Tampa, Florida, United States, North America | juventix.com/ |
| APEX Biologix | View profile | 11-50 | Murray, Utah, United States, North America | apexbiologix.com |
| Celling Biosciences | View profile | - | - | - |
Japan Platelet Rich Plasma (PRP) Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Platelet Rich Plasma (PRP) Market Outlook will help companies and investors design strategic landscapes.
Pure Prp was the largest segment with a revenue share of 59.14% in 2025.
Horizon Databook has segmented the Japan platelet rich plasma (prp) market based on pure prp, leukocyte rich prp, others type covering the revenue growth of each sub-segment from 2021 to 2033.
In 2014, the "Act on the Safety of Platelet-rich Plasma (PRP)" and the "Pharmaceuticals, Medical Devices, and Other Therapeutic Products Act” were established by Japan for the regulation of platelet concentration therapies owing to their increasing popularity. Stringent regulations have been imposed for the correct use of PRP in terms of efficacy & specificity toward certain applications and dosage.
Furthermore, Japanese researchers have proposed point-of-care testing of PRP quality in research published in April 2019. In this study, researchers have emphasized the need for point-of-care quality testing to obtain supportive evidence for platelet-rich plasma therapy.
The point-of-care testing of platelet-rich plasma is an inexpensive and useful method for determining platelet count. This method can determine platelet count in PRP preparations, further supporting the therapy. Such recommendations are expected to positively impact the adoption of PRP therapies in the country, leading to significant market growth.
- Japan Platelet Rich Plasma (Prp) Market Type Outlook (Revenue, USD Million , 2021-2033)
- Pure PRP
- Leukocyte Rich PRP
- Others Type
- Japan Platelet Rich Plasma (Prp) Market Application Outlook (Revenue, USD Million , 2021-2033)
- Orthopedics
- Sports Medicine
- Cosmetic Surgery
- Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General Surgery
- Others Application
- Japan Platelet Rich Plasma (Prp) Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Others End Use
Reasons to subscribe to Platelet Rich Plasma (PRP) Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Platelet Rich Plasma (PRP) Market Outlook databook
- Our clientele includes a mix of Platelet Rich Plasma (PRP) Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Platelet Rich Plasma (PRP) Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Platelet Rich Plasma (PRP) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Japan Platelet Rich Plasma (Prp) Market, 2021-2033 (US$M)
Japan platelet rich plasma (prp) market statistics, by type, 2021-2033 (US$M)
